Neuroleptic-induced tardive dyskinesia (TD) is a serious public health problem among chronically mentally ill older patients. There have been very few prospective, long-term studies of the incidence of and risk factors for TD in this population. We propose to evaluate, over a five-year period, 700 psychiatric patients over age 50. At study entry, these patients will have had less than 1 month of total lifetime neuroleptic exposure, and will be neuroleptic-free for at least a month prior to study entry. The initial assessments will include psychiatric and neurologic examinations (with suitable rating scales), a through review of past medical and medication records, a specific clinical evaluation of motor function and of neurologic """"""""soft"""""""" signs, a selected neuropsychological test battery, and an instrumental assessment of orofacial and limb motor function (including parkinsonism, involuntary movements and voluntary motor control). Patients will be assigned randomly to either haloperidol or thioridazine, and we will attempt to maintain them on the same neuroleptic throughout the study. The treatment will otherwise be individualized, with the goal always being to treat the patients with the lowest effective dose. Patients will be reexamined one month after initial assessment and that at 3-month intervals for evidence of TD. The neuropsychological and instrumental assessments will be repeated annually. All these evaluations will be done """"""""blind"""""""" with respect to the other data (especially treatment). The main goals of our study are: 1) to estimate the incidence of TD in this older patient population, 2) to determine the risk factors for occurrence and precipitation of TD, as well as development of a so-called """"""""malignant"""""""" form of TD, and 3) to determine the risk factors for persistence and severity of TD. Statistical methods will include survival analysis with covariates, and stepwise regression analysis. We will perform a quantitative neuropathologic study of the brains of the patients who die. The main strengths of the proposed work are: a large sample size, use of a neuropsychologic test battery, instrumental assessment of orofacial/limb motor function, a comparison of relative risk of TD with two most commonly used neuroleptics, and a neuropathologic study of the brains of TD patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH045131-04
Application #
3384758
Study Section
Treatment Development and Assessment Research Review Committee (TDA)
Project Start
1989-09-01
Project End
1994-08-31
Budget Start
1992-09-30
Budget End
1993-08-31
Support Year
4
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Wetherell, Julie Loebach; Kim, Daniel S; Lindamer, Laurie A et al. (2007) Anxiety disorders in a public mental health system: clinical characteristics and service use patterns. J Affect Disord 104:179-83
Patterson, Thomas L; Mausbach, Brent T; McKibbin, Christine et al. (2006) Functional adaptation skills training (FAST): a randomized trial of a psychosocial intervention for middle-aged and older patients with chronic psychotic disorders. Schizophr Res 86:291-9
Martin, Jennifer L; Jeste, Dilip V; Ancoli-Israel, Sonia (2005) Older schizophrenia patients have more disrupted sleep and circadian rhythms than age-matched comparison subjects. J Psychiatr Res 39:251-9
Patterson, Thomas L; Bucardo, Jesus; McKibbin, Christine L et al. (2005) Development and pilot testing of a new psychosocial intervention for older Latinos with chronic psychosis. Schizophr Bull 31:922-30
Gladsjo, Julie Akiko; McAdams, Lou Ann; Palmer, Barton W et al. (2004) A six-factor model of cognition in schizophrenia and related psychotic disorders: relationships with clinical symptoms and functional capacity. Schizophr Bull 30:739-54
Auslander, Lisa A; Jeste, Dilip V (2004) Sustained remission of schizophrenia among community-dwelling older outpatients. Am J Psychiatry 161:1490-3
Wetherell, Julie Loebach; Palmer, Barton W; Thorp, Steven R et al. (2003) Anxiety symptoms and quality of life in middle-aged and older outpatients with schizophrenia and schizoaffective disorder. J Clin Psychiatry 64:1476-82
Dolder, Christian R; Lacro, Jonathan P; Leckband, Susan et al. (2003) Interventions to improve antipsychotic medication adherence: review of recent literature. J Clin Psychopharmacol 23:389-99
Jin, Hua; Folsom, David P; Lindamer, Laurie et al. (2003) Patterns of public mental health service use by age in patients with schizophrenia. Am J Geriatr Psychiatry 11:525-33
Barrio, Concepcion; Yamada, Ann Marie; Hough, Richard L et al. (2003) Ethnic disparities in use of public mental health case management services among patients with schizophrenia. Psychiatr Serv 54:1264-70

Showing the most recent 10 out of 123 publications